Literature DB >> 28148564

Natural Selection in Cancer Biology: From Molecular Snowflakes to Trait Hallmarks.

Angelo Fortunato1, Amy Boddy2, Diego Mallo1, Athena Aktipis2,3, Carlo C Maley1,4, John W Pepper5,6.   

Abstract

Evolution by natural selection is the conceptual foundation for nearly every branch of biology and increasingly also for biomedicine and medical research. In cancer biology, evolution explains how populations of cells in tumors change over time. It is a fundamental question whether this evolutionary process is driven primarily by natural selection and adaptation or by other evolutionary processes such as founder effects and drift. In cancer biology, as in organismal evolutionary biology, there is controversy about this question and also about the use of adaptation through natural selection as a guiding framework for research. In this review, we discuss the differences and similarities between evolution among somatic cells versus evolution among organisms. We review what is known about the parameters and rate of evolution in neoplasms, as well as evidence for adaptation. We conclude that adaptation is a useful framework that accurately explains the defining characteristics of cancer. Further, convergent evolution through natural selection provides the only satisfying explanation both for how a group of diverse pathologies have enough in common to usefully share the descriptive label of "cancer" and for why this convergent condition becomes life-threatening.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28148564      PMCID: PMC5287060          DOI: 10.1101/cshperspect.a029652

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  96 in total

Review 1.  The evolutionary significance of cis-regulatory mutations.

Authors:  Gregory A Wray
Journal:  Nat Rev Genet       Date:  2007-03       Impact factor: 53.242

2.  The spandrels of San Marco and the Panglossian paradigm: a critique of the adaptationist programme.

Authors:  S J Gould; R C Lewontin
Journal:  Proc R Soc Lond B Biol Sci       Date:  1979-09-21

Review 3.  Cancer as an evolutionary and ecological process.

Authors:  Lauren M F Merlo; John W Pepper; Brian J Reid; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2006-11-16       Impact factor: 60.716

4.  Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells.

Authors:  M F Chan; R van Amerongen; T Nijjar; E Cuppen; P A Jones; P W Laird
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

5.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

Review 6.  The significance of unstable chromosomes in colorectal cancer.

Authors:  Harith Rajagopalan; Martin A Nowak; Bert Vogelstein; Christoph Lengauer
Journal:  Nat Rev Cancer       Date:  2003-09       Impact factor: 60.716

7.  The genomic complexity of primary human prostate cancer.

Authors:  Michael F Berger; Michael S Lawrence; Francesca Demichelis; Yotam Drier; Kristian Cibulskis; Andrey Y Sivachenko; Andrea Sboner; Raquel Esgueva; Dorothee Pflueger; Carrie Sougnez; Robert Onofrio; Scott L Carter; Kyung Park; Lukas Habegger; Lauren Ambrogio; Timothy Fennell; Melissa Parkin; Gordon Saksena; Douglas Voet; Alex H Ramos; Trevor J Pugh; Jane Wilkinson; Sheila Fisher; Wendy Winckler; Scott Mahan; Kristin Ardlie; Jennifer Baldwin; Jonathan W Simons; Naoki Kitabayashi; Theresa Y MacDonald; Philip W Kantoff; Lynda Chin; Stacey B Gabriel; Mark B Gerstein; Todd R Golub; Matthew Meyerson; Ashutosh Tewari; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

8.  Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers.

Authors:  Sandra Misale; Ivana Bozic; Jingshan Tong; Ashley Peraza-Penton; Alice Lallo; Federica Baldi; Kevin H Lin; Mauro Truini; Livio Trusolino; Andrea Bertotti; Federica Di Nicolantonio; Martin A Nowak; Lin Zhang; Kris C Wood; Alberto Bardelli
Journal:  Nat Commun       Date:  2015-09-22       Impact factor: 14.919

9.  Subclonal diversification of primary breast cancer revealed by multiregion sequencing.

Authors:  Lucy R Yates; Moritz Gerstung; Stian Knappskog; Christine Desmedt; Gunes Gundem; Peter Van Loo; Turid Aas; Ludmil B Alexandrov; Denis Larsimont; Helen Davies; Yilong Li; Young Seok Ju; Manasa Ramakrishna; Hans Kristian Haugland; Peer Kaare Lilleng; Serena Nik-Zainal; Stuart McLaren; Adam Butler; Sancha Martin; Dominic Glodzik; Andrew Menzies; Keiran Raine; Jonathan Hinton; David Jones; Laura J Mudie; Bing Jiang; Delphine Vincent; April Greene-Colozzi; Pierre-Yves Adnet; Aquila Fatima; Marion Maetens; Michail Ignatiadis; Michael R Stratton; Christos Sotiriou; Andrea L Richardson; Per Eystein Lønning; David C Wedge; Peter J Campbell
Journal:  Nat Med       Date:  2015-06-22       Impact factor: 53.440

10.  Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing.

Authors:  Elena Helman; Michael S Lawrence; Chip Stewart; Carrie Sougnez; Gad Getz; Matthew Meyerson
Journal:  Genome Res       Date:  2014-05-13       Impact factor: 9.043

View more
  20 in total

Review 1.  A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs).

Authors:  Christopher Larson; Bryan Oronsky; Gina Varner; Scott Caroen; Erica Burbano; Elisa Insel; Farah Hedjran; Corey A Carter; Tony R Reid
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

Review 2.  Cooperation and cheating as innovation: insights from cellular societies.

Authors:  Athena Aktipis; Carlo C Maley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-12-05       Impact factor: 6.237

3.  Comparative Molecular Life History of Spontaneous Canine and Human Gliomas.

Authors:  Samirkumar B Amin; Kevin J Anderson; C Elizabeth Boudreau; Emmanuel Martinez-Ledesma; Emre Kocakavuk; Kevin C Johnson; Floris P Barthel; Frederick S Varn; Cynthia Kassab; Xiaoyang Ling; Hoon Kim; Mary Barter; Ching C Lau; Chew Yee Ngan; Margaret Chapman; Jennifer W Koehler; James P Long; Andrew D Miller; C Ryan Miller; Brian F Porter; Daniel R Rissi; Christina Mazcko; Amy K LeBlanc; Peter J Dickinson; Rebecca A Packer; Amanda R Taylor; John H Rossmeisl; Kevin D Woolard; Amy B Heimberger; Jonathan M Levine; Roel G W Verhaak
Journal:  Cancer Cell       Date:  2020-02-10       Impact factor: 31.743

4.  Culture shock.

Authors:  Antoine Molaro; Harmit S Malik
Journal:  Elife       Date:  2017-12-18       Impact factor: 8.140

5.  SREBP1-dependent de novo fatty acid synthesis gene expression is elevated in malignant melanoma and represents a cellular survival trait.

Authors:  Su Wu; Anders M Näär
Journal:  Sci Rep       Date:  2019-07-17       Impact factor: 4.379

6.  Energy oversupply to tissues: a single mechanism possibly underlying multiple cancer risk factors.

Authors:  Daniel J Wu; Athena Aktipis; John W Pepper
Journal:  Evol Med Public Health       Date:  2019-01-21

Review 7.  A key control point in the T cell response to chronic infection and neoplasia: FOXO1.

Authors:  Nimi Marcel; Stephen M Hedrick
Journal:  Curr Opin Immunol       Date:  2020-03-02       Impact factor: 7.486

Review 8.  Helminths and Cancers From the Evolutionary Perspective.

Authors:  Larissa L S Scholte; Marcelo A Pascoal-Xavier; Laila A Nahum
Journal:  Front Med (Lausanne)       Date:  2018-04-16

Review 9.  Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions.

Authors:  Luis V Syro; Fabio Rotondo; Mauricio Camargo; Leon D Ortiz; Carlos A Serna; Kalman Kovacs
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-15       Impact factor: 5.555

Review 10.  The issues with tissues: the wide range of cell fate separation enables the evolution of multicellularity and cancer.

Authors:  Emma U Hammarlund; Sarah R Amend; Kenneth J Pienta
Journal:  Med Oncol       Date:  2020-06-13       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.